Urolog. pro Praxi, 2008; 9(5): 216-222

Ca-oxalate stones: the essential importance of prophylaxis

MUDr. Pavel Rajmon, MUDr. Zdeněk Mucha
Urologická klinika FN a LF UP v Olomouci

A mass occurence of urolithiasis presents a difficult social, medical as well as economic problem. Ca-oxalate urinary stones represent 75 % of all cases of urolithiasis. However, expensive elimination or thripsy of the urinary stones without appropriate follow-up preventive measures should have been a matter of the past. The knowledge of physiopathology of urinary stones origin as well as the knowledge of causal and risk factors enable a correct determination of preventive principles. Corresponding metaphylaxis can yield a low number of lithiasis relapses: 10–15 %. A base of the successful approach is a well- informed and motivated patient.

Keywords: Ca-oxalate stones, risk factors, prophylaxis

Published: December 20, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rajmon P, Mucha Z. Ca-oxalate stones: the essential importance of prophylaxis. Urol. praxi. 2008;9(5):216-222.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bartoníčková K. Metabolické vyšetření urolitiázy - význam, vyšetření, terapie a metafylaxe. Urolog. pro Praxi 2004; 3: 121-124.
    2. Berg C, Larson L, Tiselius HG. The effects of a single evening dose of alkaline citrate on urine composition and kalcium stone formation. J. Urol 1992; 148(3): 979-985. Go to original source... Go to PubMed...
    3. Butz M. Alkalizitratterapie bei rezidivierender Kalcium-Urolihiasis. Urologe B 1987; 27: 95-99.
    4. Cicerello E, Mero F, Gambaro G, et al. Effect of alkaline citrate therapy on clearence of residual renal stone fragments after extracorporeal shock wave lithotrypsy in steril Calcium and infection nefrolithiasis patiens. J Urol 1994; 151(1): 5-9. Go to original source... Go to PubMed...
    5. Ekeruo WO, Tan YH, Zouny MD, et al. Metabolic risk factors an the impact of medical therapy on the management of urolithiasis in obese patiens. J Urol. 2004; 172(1): 159-163. Go to original source... Go to PubMed...
    6. Ganter K, Winter P, Brockhaus S, Hesse A. Alkalisierung des Harns zur Metaphylaxe bei Klaziumoxalatsteinen K-Zitrat v. s. NaK-Zitrat. Urologe B 1996; 36(6): 461-465. Go to original source...
    7. Grasses F, Conte A, Urolithiasis, inhibitors and promoters. Urogogical Research 1992; 20(1): 86-88. Go to original source... Go to PubMed...
    8. Hartmann RE, Strub M. Harnsteine. Urologe A 2006; 45(Supplement 4): 181-184. Go to original source... Go to PubMed...
    9. Hess B, Maura H, Ackermann D, Jaeger P. Effects of a, ,common sense diet" on urinary composition and supersaturation in pacients with idiophatic calcium urolitihiasis. Eur. Urol. 1999; 36(2): 136-143. Go to original source... Go to PubMed...
    10. Hesse A, Urinary calculi 2: metabolic defects nutrition errors and metaphylaxis. Urologe A 2002; 41(6): 616-628. Go to original source... Go to PubMed...
    11. Hesse A, Brandle E, Gilbert DM, Koehrmann KU, Alken P. Aktuelle Daten zur Prävalenz und Inzidenz des Harnsteinleidens in Deutschland. Deutscher Urologen-kongress Wiesbaden 2002.
    12. Khazim A. Metabolické poruchy u pacientů s urolitiázou. Urol. Listy 2004; 2: 12-15.
    13. Kočvara R, Ptáček V, Ťuíková J. Metafylaxe urolitiázy, způsob a výsledky. Čas. Lék. čes. 1989; 128: 266-269.
    14. Křížek V, Sadílek L. Urolitiáza, etiopatogeneze, konzervativní terapie a prevence. Praha: Avicenum, 1990.
    15. Pak CY, Fuller C, Sakhall K, Preminger GM, Brittan F Long - term treatment of calcium nefrolithiasis with potassium citrat. J. Urol. 1985; 134(1): 11-12. Go to original source... Go to PubMed...
    16. Rinnab L, Hautmann RE, Straub M. Alkalitzitrate in der Urologie. Urologe A 2004; 43(4): 429-439. Go to original source... Go to PubMed...
    17. Stejskal D. Etiopatogeneze a metafylaxe metabolických poruch a rizik urolitiázy. Interní Med. 2003; 1: 8-14.
    18. Stejskal D. Urolitiáza: etiopatogeneze, diagnostika, primární a sekundární prevence. Praha: Grada, 2007.
    19. Straub M, Hautmann RE. Prävention der Nefrolitihiasis. Bewährte Strategie und neue Konzepte. Urologe A 2004; 43(4): 440-449. Go to original source... Go to PubMed...
    20. Straub M, Hautmann RE, Hesse A, Rinnab L. Kalciumoxalatharnsteine und Hyperoxalurie. Urologe A 2005; 44(11): 1315-1323. Go to original source... Go to PubMed...
    21. Tisselius HG, Alken P, Buck C, Galluci M, Knoll T, Soreca K, Türk Ch. Guidelines on Urolithiasis in: EAU Guidelines 2008.
    22. Wilbert DM, Wechsel HW, Lahme S. Diagnostik und Therapie der Urolithiasis-Tübinger Koncept. Urologe B 1998; 38(6): 509-521. Go to original source...
    23. Zvara V, Revúsová V. Močové konkrementy; Veda 1988.

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.